发明名称 Use of compounds for the elevation of pyruvate dehydrogenase activity
摘要 The use of compounds of the formula (I), and salts thereof; and pharmaceutically acceptable in vivo cleavable prodrugs of said compound of formula (I); and pharmaceutically acceptable salts of said compound or said prodrugs:wherein:Ring C is phenyl or a carbon linked heteroaryl ring substituted as defmed within;R1 is an ortho substituent as defined within;n is 1 or 2;A-B is a linking group as defined within;R2 and R3 are as defined within;R4 is hydroxy, hydrogen, halo, amino or methyl; in the manufacture of a medicament for use in the elevation of PDH activity in warm-blooded animals such as humans is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
申请公布号 US6498275(B1) 申请公布日期 2002.12.24
申请号 US20000700370 申请日期 2000.11.15
申请人 ASTRAZENECA AB 发明人 BUTLIN ROGER J;NOWAK THORSTEN;BURROWS JEREMY N;BLOCK MICHAEL H
分类号 C07D249/12;A61K31/165;A61K31/167;A61K31/18;A61K31/26;A61K31/27;A61K31/341;A61K31/4015;A61K31/41;A61K31/415;A61K31/4184;A61K31/42;A61K31/421;A61K31/423;A61K31/4245;A61K31/426;A61K31/428;A61K31/433;A61K31/44;A61K31/4409;A61K31/445;A61K31/454;A61K31/495;A61K31/496;A61K31/4965;A61K31/50;A61K31/505;A61K31/517;A61K31/5355;A61K31/5375;A61K31/5377;A61K31/54;A61K31/541;A61P3/06;A61P3/10;A61P9/04;A61P9/08;A61P9/10;A61P21/00;A61P25/28;A61P43/00;C07C235/16;C07C317/38;C07C317/40;C07C317/42;C07C317/44;C07C323/65;C07D207/08;C07D207/12;C07D207/263;C07D207/48;C07D211/14;C07D211/22;C07D211/42;C07D211/46;C07D213/70;C07D213/71;C07D213/75;C07D213/82;C07D213/89;C07D231/14;C07D231/40;C07D233/84;C07D233/90;C07D235/26;C07D237/20;C07D239/26;C07D239/38;C07D239/42;C07D239/46;C07D239/96;C07D241/20;C07D257/04;C07D261/10;C07D261/14;C07D263/46;C07D263/56;C07D263/58;C07D271/06;C07D277/04;C07D277/20;C07D277/36;C07D277/74;C07D277/76;C07D285/125;C07D295/08;C07D295/096;C07D295/12;C07D295/13;C07D295/14;C07D295/15;C07D295/18;C07D295/192;C07D295/205;C07D295/24;C07D295/26;C07D307/52;(IPC1-7):C07C233/05;A61K31/16 主分类号 C07D249/12
代理机构 代理人
主权项
地址